JP4593106B2 - 着床前因子の新しいアッセイ方法および着床前因子ペプチド - Google Patents

着床前因子の新しいアッセイ方法および着床前因子ペプチド Download PDF

Info

Publication number
JP4593106B2
JP4593106B2 JP2003510760A JP2003510760A JP4593106B2 JP 4593106 B2 JP4593106 B2 JP 4593106B2 JP 2003510760 A JP2003510760 A JP 2003510760A JP 2003510760 A JP2003510760 A JP 2003510760A JP 4593106 B2 JP4593106 B2 JP 4593106B2
Authority
JP
Japan
Prior art keywords
pif
isolated peptide
ser
peptide
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2003510760A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005512953A (ja
JP2005512953A5 (https=
Inventor
バーネア、エイタン
レネー ゴンザレズ ペレズ、ルベン
リービス、ポール、シー．
Original Assignee
バイオインセプト、エルエルシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイオインセプト、エルエルシー filed Critical バイオインセプト、エルエルシー
Publication of JP2005512953A publication Critical patent/JP2005512953A/ja
Publication of JP2005512953A5 publication Critical patent/JP2005512953A5/ja
Application granted granted Critical
Publication of JP4593106B2 publication Critical patent/JP4593106B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70507—C2D

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2003510760A 2001-07-02 2002-06-28 着床前因子の新しいアッセイ方法および着床前因子ペプチド Expired - Fee Related JP4593106B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30260701P 2001-07-02 2001-07-02
PCT/US2002/020599 WO2003004601A2 (en) 2001-07-02 2002-06-28 New assays for preimplantation factor and preimplantation factor peptides

Publications (3)

Publication Number Publication Date
JP2005512953A JP2005512953A (ja) 2005-05-12
JP2005512953A5 JP2005512953A5 (https=) 2006-01-19
JP4593106B2 true JP4593106B2 (ja) 2010-12-08

Family

ID=23168483

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003510760A Expired - Fee Related JP4593106B2 (ja) 2001-07-02 2002-06-28 着床前因子の新しいアッセイ方法および着床前因子ペプチド

Country Status (12)

Country Link
US (8) US7273708B2 (https=)
EP (1) EP1404877B1 (https=)
JP (1) JP4593106B2 (https=)
CN (5) CN101059510A (https=)
AT (1) ATE454399T1 (https=)
AU (1) AU2002320198B2 (https=)
CA (1) CA2490538C (https=)
DE (1) DE60235011D1 (https=)
IL (6) IL159671A0 (https=)
MX (1) MXPA04000151A (https=)
NZ (1) NZ530723A (https=)
WO (1) WO2003004601A2 (https=)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8012700B2 (en) 2001-07-02 2011-09-06 Bioincept, Llc Assays for preimplantation factor and preimplantation factor peptides
US8454967B2 (en) 2004-10-22 2013-06-04 Bioincept Llc Compositions and methods for modulating the immune system
US9737585B2 (en) 2011-03-02 2017-08-22 Bioincept, Llc Compositions and methods for treatment of intracellular damage and bacterial infection
US11090355B2 (en) 2015-08-28 2021-08-17 Bioincept, Llc Compositions and methods for the treatment of neurodamage

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8222211B2 (en) * 2001-07-02 2012-07-17 Bioincept, Llc Methods of administering PIF agonist peptides and uses thereof
EP1680442B1 (en) * 2003-10-22 2011-07-13 Bioincept, LLC. Pif peptides biologic activities
WO2005040196A2 (en) 2003-10-22 2005-05-06 Bioincept, Llc Pif peptides biologic activities, site of action, and the antibody to detect pif
US7723289B2 (en) * 2003-10-22 2010-05-25 Bioincept, Llc PIF tetrapeptides
WO2017039751A1 (en) 2015-08-28 2017-03-09 Bioincept, Llc Mutant peptides and methods of treating subjects using the same
EP2970496B1 (en) 2013-03-12 2018-07-18 Institute of Arthritis Research LLC Immunologically active polypeptide
AU2015343202A1 (en) * 2014-11-03 2017-05-25 Bioincept, Llc PIF binding as a marker for immune dysregulation
CA3054366A1 (en) * 2017-02-22 2018-08-30 Bioincept, Llc Peptides and methods of treating dystrophy-related disorders using the same
US20240228620A1 (en) 2022-10-06 2024-07-11 Bicara Therapeutics Inc. Multispecific proteins and related methods

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US564003A (en) * 1896-07-14 chase
US6352694B1 (en) 1994-06-03 2002-03-05 Genetics Institute, Inc. Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
US5279941A (en) 1992-06-12 1994-01-18 Trustees Of The University Of Pennsylvania Determination of endometrial receptivity toward embryo implantation
AU5130793A (en) * 1992-09-17 1994-04-12 New York University Compositions and methods for inhibiting hepatocyte invasion by malarial sporozoites
US5646003A (en) 1994-03-23 1997-07-08 Barnea; Eytan R. Preimplantation factor
GB9406492D0 (en) 1994-03-31 1994-05-25 Isis Innovation Malaria peptides
US6489441B1 (en) * 1995-09-01 2002-12-03 The Salk Institute For Biological Studies Transcriptional co-repressor that interacts with nuclear hormone receptors
US6585979B1 (en) 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
US6171591B1 (en) * 1997-12-08 2001-01-09 Pentamer Pharmaceuticals, Inc. Recombinant nodavirus compositions and methods
US20020004205A1 (en) 2000-03-30 2002-01-10 Consler Thomas G. Method of investigating functional molecular interactions and reagents for use therein
EP1355664A4 (en) 2001-01-04 2005-10-26 Vascular Biogenics Ltd METHODS INVOLVING MOLECULES ASSOCIATED WITH ATHEROSCLEROSIS PLATES AND COMPOSITIONS CONTAINING THESE MOLECULES FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS
US8222211B2 (en) 2001-07-02 2012-07-17 Bioincept, Llc Methods of administering PIF agonist peptides and uses thereof
US7273708B2 (en) 2001-07-02 2007-09-25 Bioincept, Llc Assays for preimplantation factor and preimplantation factor peptides
WO2004053086A2 (en) 2002-12-06 2004-06-24 Epimmune, Inc. Plasmodium falciparum antigens and methods of use
US7156272B2 (en) * 2003-08-22 2007-01-02 Frank Dean Golf bag carrier for a motorcycle
US7723289B2 (en) 2003-10-22 2010-05-25 Bioincept, Llc PIF tetrapeptides
US7723290B2 (en) 2004-10-22 2010-05-25 Bioincept, Llc Compositions and methods for modulating the immune system
WO2005040196A2 (en) 2003-10-22 2005-05-06 Bioincept, Llc Pif peptides biologic activities, site of action, and the antibody to detect pif

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8012700B2 (en) 2001-07-02 2011-09-06 Bioincept, Llc Assays for preimplantation factor and preimplantation factor peptides
US8454967B2 (en) 2004-10-22 2013-06-04 Bioincept Llc Compositions and methods for modulating the immune system
US10071131B2 (en) 2006-02-03 2018-09-11 Bioincept, Llc Compositions and methods for modulating the immune system
US10806771B2 (en) 2006-02-03 2020-10-20 Bioincept, Llc Compositions and methods for modulating the immune system
US9737585B2 (en) 2011-03-02 2017-08-22 Bioincept, Llc Compositions and methods for treatment of intracellular damage and bacterial infection
US10953071B2 (en) 2011-03-02 2021-03-23 Bioincept, Llc Compositions and methods for treatment of intracellular damage and bacterial infection
US11090355B2 (en) 2015-08-28 2021-08-17 Bioincept, Llc Compositions and methods for the treatment of neurodamage

Also Published As

Publication number Publication date
US20120009605A1 (en) 2012-01-12
DE60235011D1 (de) 2010-02-25
EP1404877A4 (en) 2007-07-11
NZ530723A (en) 2006-02-24
IL159671A (en) 2010-12-30
US7273708B2 (en) 2007-09-25
CA2490538A1 (en) 2003-01-16
EP1404877B1 (en) 2010-01-06
US7670852B2 (en) 2010-03-02
IL209509A0 (en) 2011-01-31
CN102875646B (zh) 2014-04-16
US20090011427A1 (en) 2009-01-08
CA2490538C (en) 2011-08-16
US20080305552A1 (en) 2008-12-11
US20050064520A1 (en) 2005-03-24
US20080305468A1 (en) 2008-12-11
CN1522306A (zh) 2004-08-18
CN103755787A (zh) 2014-04-30
EP1404877A2 (en) 2004-04-07
US20080293149A1 (en) 2008-11-27
US20080299677A1 (en) 2008-12-04
ATE454399T1 (de) 2010-01-15
CN102875646A (zh) 2013-01-16
US8012700B2 (en) 2011-09-06
JP2005512953A (ja) 2005-05-12
IL209509A (en) 2012-08-30
US7695977B2 (en) 2010-04-13
IL159671A0 (en) 2004-06-01
IL209481A0 (en) 2011-01-31
IL209472A (en) 2014-02-27
IL209481A (en) 2014-02-27
CN102174079B (zh) 2013-09-11
AU2002320198B2 (en) 2007-10-04
CN103755787B (zh) 2016-05-18
IL194710A (en) 2014-06-30
US7678582B2 (en) 2010-03-16
CN100339388C (zh) 2007-09-26
MXPA04000151A (es) 2005-06-06
CN101059510A (zh) 2007-10-24
WO2003004601A3 (en) 2003-12-04
IL209472A0 (en) 2011-01-31
US7670850B2 (en) 2010-03-02
WO2003004601A2 (en) 2003-01-16
CN102174079A (zh) 2011-09-07
US7670851B2 (en) 2010-03-02
US20100197040A1 (en) 2010-08-05

Similar Documents

Publication Publication Date Title
US7678582B2 (en) Assays for preimplantation factor and preimplantation factor peptides
AU2002320198A1 (en) New assays for preimplantation factor and preimplantation factor peptides
US7723289B2 (en) PIF tetrapeptides
AU2004284097B2 (en) PIF peptides biologic activities, site of action, and the antibody to detect PIF
US8222211B2 (en) Methods of administering PIF agonist peptides and uses thereof
JPH10509581A (ja) トロフィニンおよびトロフィニン補助タンパク質
CA2894868C (en) Pif peptides biologic activities, site of action, and the antibody to detect pif

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050622

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050622

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051121

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080129

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20080409

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20080416

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080729

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090519

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090808

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090817

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091117

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20091117

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100609

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100722

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20100727

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100817

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100915

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130924

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4593106

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees